Tagged with P

Bayer Bayer Malaysia’s managing director, Thomas Steffen, discusses the key differences and opportunities offered by the Malaysian market and calls for more information to help the promotion of oral contraception in order to strengthen women’s role in society. As you are managing the pharmaceutical business in both Malaysia and Singapore, how…

DHL DHL Supply Chain has made great strides in recent years to invest in healthcare logistics in Spain. Francisco Milián, chief customer officer of the company’s Spanish affiliate outlines these investments discusses the need for greater efficiency across the Iberian peninsula for the delivery of healthcare products.   What have been…

innovation Recognizing the value of innovation is fundamental for the success of every pharmaceutical company operating in Korea. Lee Sang-Suk, CEO of the Korean Research-based Pharmaceutical industry Association (KRPIA), demonstrates the commitment of multinationals to Korea to help illustrate the benefits of innovation that Koreans can access.     What is…

regulation The Indian joint secretary for commerce and industry, interviewed at CPhI Worldwide 2014 in Paris, discusses India’s place in the global pharmaceutical landscape, and emphasizes the country’s contribution to the world’s health.   India has gone to great lengths at this CPhI conference to brand itself and show the world…

compliance The president of CETIFARMA, the council created by the pharmaceutical industry in Mexico for ethics and transparency, discusses the tireless effort it has made to professionalize the compliance function in the industry as well as the growing importance of transparency and ethics in its relation with physicians and patients.  …

chamber of commerce The European Chamber of Commerce in Korea (ECCK) was founded in 2012, in order to represent the interests of European businesses in Korea. Christoph Heider, secretary general of ECCK, discusses the initial challenges involved in establishing the chamber, as well as his outlook on the challenges and opportunities that the…

orphan drugs Gabriela Pittis discusses the Argentinian healthcare system’s ability to diagnose, treat, and regulate rare diseases, and the country’s progress in further developing what is already the region’s most comprehensive system in this regard.   Is the Argentinian system able to reliably diagnose and treat rare diseases? “Rare diseases” is a…

Egypt The table below shows highlighted markets in the MENA region, and their performance in 2013. Saudi Arabia is the largest pharma market in the region, with Iraq as the fastest growing market.

regulation The executive director of the board bringing together multinational and local drug manufacturers talks about the chamber’s goal to position the pharmaceutical industry as the most important manufacturing sector in Mexico, how the chamber is working with the government and its membership to reach this goal and which new dynamics are…

Spain Spain has seen a number of investments in recent months in the pharmaceutical sector: below is a non-comprehensive list of R&D, manufacturing, and clinical trials by international pharma companies.

Spain The following graph shows that the pharma is the leading sector when it comes to R&D in Spain, accounting for 20.2 percent of investment in 2013.

Spain The following infographic shows the main locations of the pharma sector in Spain, as well as the number of companies based in each region of the country.